AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,726,026 | -19.7% | 479,540 | 0.0% | 0.10% | -9.1% |
| Q2 2023 | $4,641,947 | -11.7% | 479,540 | 0.0% | 0.11% | -12.0% |
| Q1 2023 | $5,255,758 | +153.7% | 479,540 | 0.0% | 0.12% | +150.0% |
| Q4 2022 | $2,071,613 | -74.2% | 479,540 | -55.0% | 0.05% | -75.8% |
| Q3 2022 | $8,019,000 | -2.1% | 1,066,408 | +30.8% | 0.21% | -13.0% |
| Q2 2022 | $8,192,000 | -14.2% | 815,126 | +5.7% | 0.24% | -0.8% |
| Q1 2022 | $9,545,000 | -8.7% | 771,018 | +68.6% | 0.24% | -0.8% |
| Q4 2021 | $10,456,000 | -23.0% | 457,173 | -25.5% | 0.24% | -15.1% |
| Q3 2021 | $13,572,000 | +33.3% | 613,269 | -22.0% | 0.28% | +41.8% |
| Q2 2021 | $10,184,000 | +0.3% | 785,769 | +0.5% | 0.20% | -9.0% |
| Q1 2021 | $10,149,000 | -5.1% | 781,569 | +1.0% | 0.22% | -2.6% |
| Q4 2020 | $10,700,000 | -6.0% | 773,669 | +0.1% | 0.23% | -21.5% |
| Q3 2020 | $11,380,000 | – | 772,569 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |